Literature DB >> 29359453

Strong xenoprotective function by single-copy transgenes placed sequentially at a permissive locus.

Beate Rieblinger1, Konrad Fischer1, Alexander Kind1, Benedikt S Saller1, Wiebke Baars2, Marion Schuster3, Lelia Wolf-van Buerck3, Andrea Schäffler1, Tatiana Flisikowska1, Mayuko Kurome4, Valeri Zakhartchenko4, Barbara Kessler4, Krzysztof Flisikowski1, Eckhard Wolf4, Jochen Seissler3, Reinhard Schwinzer2, Angelika Schnieke1.   

Abstract

BACKGROUND: Multiple xenoprotective transgenes are best grouped at a single locus to avoid segregation during breeding and simplify production of donor animals.
METHODS: We used transgene stacking to place a human CD55 transgene adjacent to a human heme oxygenase 1 construct at the porcine ROSA26 locus. A transgenic pig was analyzed by PCR, RT-PCR, droplet digital PCR, immunohistochemistry, immunofluorescence, and flow cytometry. Resistance to complement-mediated cell lysis and caspase 3/7 activation were determined in vitro.
RESULTS: The ROSA26 locus was retargeted efficiently, and animals were generated by nuclear transfer. RNA and protein analyses revealed abundant expression in all organs analyzed, including pancreatic beta cells. Transgenic porcine kidney fibroblasts were almost completely protected against complement-mediated lysis and showed reduced caspase 3/7 activation.
CONCLUSION: Step-by-step placement enables highly expressed single-copy xenoprotective transgenes to be grouped at porcine ROSA26.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990ROSA26zzm321990; CD55; heme oxygenase 1; transgene stacking; xenotransplantation

Mesh:

Substances:

Year:  2018        PMID: 29359453     DOI: 10.1111/xen.12382

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  5 in total

1.  A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies.

Authors:  Tatiana Flisikowska; Jerome Egli; Angelika Schnieke; Antonio Iglesias; Krzysztof Flisikowski; Marlene Stumbaum; Erich Küng; Martin Ebeling; Roland Schmucki; Guy Georges; Thomas Singer; Mayuko Kurome; Barbara Kessler; Valeri Zakhartchenko; Eckhard Wolf; Felix Weber
Journal:  Nat Biomed Eng       Date:  2022-09-22       Impact factor: 29.234

2.  A desirable transgenic strategy using GGTA1 endogenous promoter-mediated knock-in for xenotransplantation model.

Authors:  Nayoung Ko; Joohyun Shim; Hyoung-Joo Kim; Yongjin Lee; Jae-Kyung Park; Kyungmin Kwak; Jeong-Woong Lee; Dong-Il Jin; Hyunil Kim; Kimyung Choi
Journal:  Sci Rep       Date:  2022-06-10       Impact factor: 4.996

Review 3.  Cardiac xenotransplantation: a promising way to treat advanced heart failure.

Authors:  Songren Shu; Jie Ren; Jiangping Song
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

Review 4.  Xenotransplantation becoming reality.

Authors:  Konrad Fischer; Angelika Schnieke
Journal:  Transgenic Res       Date:  2022-05-11       Impact factor: 3.145

5.  Allelic Expression Imbalance Analysis Identified YAP1 Amplification in p53- Dependent Osteosarcoma.

Authors:  Guanglin Niu; Agnieszka Bak; Melanie Nusselt; Yue Zhang; Hubert Pausch; Tatiana Flisikowska; Angelika E Schnieke; Krzysztof Flisikowski
Journal:  Cancers (Basel)       Date:  2021-03-18       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.